Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 6/20 | 0.38 |
| ▸ | HTR2C | P28335 | 5/20 | 0.34 |
| ▸ | HTR2B | P41595 | 4/20 | 0.34 |
| ▸ | HTR2A | P28223 | 3/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13264398 | 0.87 | HTR2C (0.34) | HTR2CHTR2BHTR2A | |
| SCHEMBL13762035 | 0.86 | HTR2C (0.36) | HTR2CHTR2BHTR2A | |
| SCHEMBL13762037 | 0.86 | HPGD (0.38) | SCN9AHTR2CHTR2BHTR2A | |
| SCHEMBL13762038 | 0.85 | HTR2C (0.33) | HTR2CHTR2BHTR2A | |
| SCHEMBL13235554 | 0.81 | SCN9A (0.41) | SCN9AHTR2CHTR2BHTR2ALRRK2 | |
| SCHEMBL13264595 | 0.78 | HTR2C (0.34) | HTR2CHTR2BHTR2A | |
| SCHEMBL13264596 | 0.77 | HPGD (0.40) | SCN9AHTR2CHTR2BHTR2A | |
| SCHEMBL9920720 | 0.76 | HTR2C (0.36) | HTR2CHTR2BHTR2A | |
| SCHEMBL13762091 | 0.76 | HTR2C (0.34) | HTR2CHTR2BHTR2A | |
| SCHEMBL12388763 | 0.75 | HTR2C (0.38) | HTR2CHTR2BHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7758931-B2 | Chlorofluorobenzene liquid crystal compound, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-20090264683-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264683-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CCND3, CCND1, SLFN12 | SCN9A 1801/4885HTR2C 663/4885HTR2B 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.